Omnicell OMCL Product revenues — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Omnicell in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Omnicell's product revenues — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Omnicell's product revenues — total revenues?
- Omnicell (OMCL) reported product revenues — total revenues of $174.8M in Q1 2026.
- How has Omnicell's product revenues — total revenues changed year-over-year?
- Omnicell's product revenues — total revenues increased by 20.4% year-over-year, from $145.17M to $174.8M.
- What is the long-term trend for Omnicell's product revenues — total revenues?
- Over 4 years (2021 to 2025), Omnicell's product revenues — total revenues has grown at a -4.9% compound annual growth rate (CAGR), from $812.51M to $665.7M.
- What does product revenues — total revenues mean?
- This metric represents the total gross revenue generated specifically from the sale of physical products within the company's medication management portfolio. It serves as a primary indicator of market demand for the company's hardware and automation systems. Tracking this figure helps investors assess the company's ability to scale its core product offerings within healthcare facilities.